XML 43 R29.htm IDEA: XBRL DOCUMENT v3.26.1
REVENUE (Tables)
6 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents disaggregated net product sales in the periods presented as follows (in thousands):
Three Months Ended
June 30,
Six Months Ended
June 30,
2026202520262025
Net product sales:
   EXPAREL$147,823 $142,917 $291,097 $279,446 
   ZILRETTA32,648 31,334 59,415 54,672 
   iovera° (1)
6,806 5,588 12,982 10,711 
   Bupivacaine liposome injectable suspension3,216 508 4,375 3,112 
      Total net product sales$190,493 $180,347 $367,869 $347,941 
(1) In June 2026, the Company entered into the Purchase Agreement with Zimmer to divest iovera°. The Transaction closed on July 31, 2026, after which the Company will no longer recognize revenue associated with iovera°. For more information, see Note 3, Assets and Liabilities Held for Sale.